PMV Pharmaceuticals Ownership | Who Owns PMV Pharmaceuticals?

PMV Pharmaceuticals Ownership Summary

PMV Pharmaceuticals is owned by 26.57% institutional investors, 3.23% insiders, and 70.20% retail investors. Orbimed advisors is the largest institutional shareholder, holding 12.46% of PMVP shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.94% of its assets in PMV Pharmaceuticals shares.

PMVP Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	PMV Pharmaceuticals	26.57%	3.23%	70.20%
Sector	Healthcare Stocks	279.42%	10.64%	-190.05%
Industry	Biotech Stocks	64.05%	10.69%	25.27%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Orbimed advisors	6.48M	12.46%	$7.06M
Sio capital management	3.74M	7.19%	$4.07M
Arrowmark colorado	3.51M	6.80%	$5.30M
Bml capital management	3.47M	6.72%	$5.23M
Pfm health sciences, lp	3.30M	6.36%	$3.60M
Euclidean capital	2.63M	5.09%	$3.97M
Alkeon capital management	2.34M	4.54%	$3.54M
Vanguard group	2.14M	4.16%	$3.24M
Acadian asset management	2.08M	4.03%	$3.14M
Blackrock	1.16M	2.26%	$1.88M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Bml capital management	3.47M	3.25%	$5.23M
Sio capital management	3.74M	1.21%	$4.07M
Aldebaran capital	502.19K	0.72%	$758.31K
Stonepine capital management	535.80K	0.65%	$809.07K
Euclidean capital	2.63M	0.54%	$3.97M
Pfm health sciences, lp	3.30M	0.26%	$3.60M
Orbimed advisors	6.48M	0.17%	$7.06M
Arrowmark colorado	3.51M	0.07%	$5.30M
Velan capital investment management lp	35.00K	0.04%	$38.15K
Adar1 capital management	101.01K	0.02%	$110.10K

Top Buyers

Holder	Shares	% Assets	Change
Bml capital management	3.47M	3.25%	1.78M
Pfm health sciences, lp	3.30M	0.26%	1.22M
Stonepine capital management	535.80K	0.65%	535.80K
Sio capital management	3.74M	1.21%	163.23K
Ubs group	275.46K	0.00%	96.60K

Top Sellers

Holder	Shares	% Assets	Change
Blackrock	1.16M	-	-1.95M
Bank of america corp /de/	340.39K	-	-1.03M
State street	145.08K	-	-640.91K
Ecor1 capital	-	-	-566.88K
Personal cfo solutions	-	-	-550.34K

New Positions

Holder	Shares	% Assets	Change	Value
Stonepine capital management	535.80K	0.65%	535.80K	$809.07K
Russell investments group	4.71K	-	4.71K	$7.63K
Macquarie group	2.08K	-	2.08K	$3.37K
Bnp paribas arbitrage, snc	763.00	-	763.00	$1.15K

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-8.00
Nisa investment advisors	-105.00
Avion wealth	-299.00
Capital advisors	-322.00
New york state common retirement fund	-341.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2025	6	-91.67%	13,804,026	-64.57%	26	0.47%	2	-90.48%	1	-96.77%
Dec 31, 2024	23	-69.33%	12,134,994	-68.90%	23	0.41%	7	-75.00%	8	-72.41%
Sep 30, 2024	75	-19.35%	39,023,924	-3.62%	75	1.22%	29	-35.56%	29	-6.45%
Jun 30, 2024	93	-7.00%	40,490,486	-5.27%	78	1.14%	45	-10.00%	31	19.23%
Mar 31, 2024	100	-2.91%	42,741,191	-8.02%	83	0.93%	50	-13.79%	26	-13.33%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard US Total Market Shares ETF	1.52M	2.94%	-
Vanguard Total Stock Mkt Idx Inv	1.52M	2.93%	-
Meridian Small Cap Growth Legacy	1.26M	2.42%	-
ArrowMark Small Cap Gro	1.26M	2.42%	-
ACAP Strategic A	1.15M	2.21%	-
SQUAD Aguja Opportunities I	570.00K	1.10%	-
Vanguard Institutional Extnd Mkt Idx Tr	540.35K	1.04%	-
BlackRock Advantage Small Cap Core Instl	280.44K	0.54%	-
Goldman Sachs Small Cp Val Insghts Instl	249.01K	0.48%	-
Fidelity Extended Market Index	210.94K	0.41%	-551.00

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jul 01, 2025	Ticktin Robert	General Counsel & COO	Sell	$24.65K
Jul 01, 2025	Jalota Deepika	Chief Development Officer	Sell	$35.20K
Jul 01, 2025	Carulli Michael	Chief Financial Officer	Sell	$30.08K
Jul 01, 2025	Mack David Henry	President and CEO	Sell	$62.18K
Sep 11, 2024	Jalota Deepika	Chief Development Officer	Sell	$10.85K

Insider Transactions Trends

Date	Buy	Sell
2025 Q3	-	4
2025 Q2	-	-
2025 Q1	-	-
2024 Q4	-	-
2024 Q3	-	2

PMVP Ownership FAQ

Who Owns PMV Pharmaceuticals?

PMV Pharmaceuticals shareholders are primarily institutional investors at 26.57%, followed by 3.23% insiders and 70.20% retail investors. The average institutional ownership in PMV Pharmaceuticals's industry, Biotech Stocks , is 64.05%, which PMV Pharmaceuticals falls below.

Who owns the most shares of PMV Pharmaceuticals?

PMV Pharmaceuticals’s largest shareholders are Orbimed advisors (6.48M shares, 12.46%), Sio capital management (3.74M shares, 7.19%), and Arrowmark colorado (3.51M shares, 6.80%). Together, they hold 26.46% of PMV Pharmaceuticals’s total shares outstanding.

Does Blackrock own PMV Pharmaceuticals?

Yes, BlackRock owns 2.26% of PMV Pharmaceuticals, totaling 1.16M shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 1.88M$. In the last quarter, BlackRock decreased its holdings by -1.948M shares, a -62.63% change.

Who is PMV Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Bml capital management is PMV Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 3.25% of its assets in 3.47M PMV Pharmaceuticals shares, valued at 5.23M$.

Who is the top mutual fund holder of PMV Pharmaceuticals shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of PMV Pharmaceuticals shares, with 2.94% of its total shares outstanding invested in 1.52M PMV Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools